Establishing a pooled procurement mechanism for African pharmaceutical manufacturers is essential if the continent is to reduce its reliance on imports, delegates at an official Group of 20 (G20) side event agreed on Monday.

The recent freeze in US aid, with a sharp reduction in European overseas assistance, has once again highlighted Africa’s lack of production capacity for vital medical supplies, an issue that shot to the fore during the Covid-19 pandemic when African nations were last in line for vaccines when they were in short supply...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.